or
forgot password
  • cancer clinical trials in charlottesville, VA

  • Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Breast Neoplasms
    Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Study of Kidney Tumors in Young Patients
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Kidney Cancer, Nonneoplastic Condition
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Neuroblastoma
    Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Hepatocellular Carcinoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
    University of Virginia
    Charlottesville, Virginia 22908
    Obesity, Hyperandrogenemia, Polycystic Ovary Syndrome
    Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer
    University of Virginia Health Sciences Center
    Charlottesville, Virginia 22098
    Breast Cancer
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Prostate Cancer, Sexual Dysfunction
    Pilot Study of Infrared Imaging of Cutaneous Melanoma
    University of Virginia
    Charlottesville, Virginia 22908
    Melanoma
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    University of Virginia
    Charlottesville, Virginia 22908
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Leukemia
    Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
    University of Virginia Health System/Division of Neuro-Oncology
    Charlottesville, Virginia 22908
    Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma
    Multicenter Hologic Tomosynthesis Study
    University of Virginia
    Charlottesville, Virginia 22908
    Breast Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
    University of Virginia
    Charlottesville, Virginia 22908
    Bone Metastases
    Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Martha Jefferson Hospital Cancer Care Center
    Charlottesville, Virginia 22901
    Breast Cancer, Cardiac Toxicity
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Pancreatic Cancer
    Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Breast Cancer
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Peripheral T-cell Lymphoma
    A Multi-center Clinical Trial of the Misago(TM) Self-Expanding Stent System for Superficial Femoral Artery
    University of Virginia
    Charlottesville, Virginia 22908
    Peripheral Vascular Disease
    RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma, Adult Ependymoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma
    Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma
    Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
    University of Virginia
    Charlottesville, Virginia 22908
    Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Meningeal Hemangiopericytoma, Adult Papillary Meningioma, Neurofibromatosis Type 1, Neurofibromatosis Type 2, Recurrent Adult Brain Tumor
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    University of Virginia
    Charlottesville, Virginia 22908
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Leukemia
    Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC)
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Non-small Cell Lung Cancer
    Neoadjuvant Therapy for Ovarian Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    University of Virginia Cancer Center

    Trial Locations
    University of Virginia Cancer Center
    Martha Jefferson Hospital Cancer Care Center
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    New Treatment for Alcohol and Nicotine Dependence
    University of Virginia Center for Addiction Research & Education
    Charlottesville, Virginia 22911
    Alcohol Dependence, Nicotine Dependence
    Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Cancer
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    University of Virginia
    Charlottesville, Virginia 22908
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    University of Virginia Health Systems Univ Virginia
    Charlottesville, Virginia 22908-0334
    Metastatic Renal Cell Carcinoma
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    University of Virginia
    Charlottesville, Virginia 22908
    Chronic Myelogenous Leukemia in Chronic Phase
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    A Prospective Trial of COXEN Chemotherapy Prediction
    University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Neoplasms, Fallopian Tube Neoplasms
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    University of Virginia
    Charlottesville, Virginia 22908
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Safety and Efficacy of PCI-32765 in Subjects With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
    University of Virginia School of Medicine Hospital
    Charlottesville, Virginia 22908
    Mantle Cell Lymphoma
    Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
    University of Virginia Urology Department
    Charlottesville, Virginia 22908
    Bladder Cancer
    Aldesleukin With or Without Aflibercept in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    University of Virginia
    Charlottesville, Virginia 22908
    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Glioblastoma Multiforme
    Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Efficacy and Safety Study of CAL-101 in Patients With Indolent B-Cell Non-Hodgkin Lymphoma
    University of Virginia Medical Center
    Charlottesville, Virginia 22908
    Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
    ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids
    University of Virginia Health System
    Charlottesville, Virginia 22903
    Uterine Fibroid(s)
    Amgen 386 for Recurrent Glioblastoma
    University of Virginia
    Charlottesville, Virginia 22908
    Glioblastoma Multiforme
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    University of Virginia Health Systems SC-1
    Charlottesville, Virginia 22908-0334
    Non-small Cell Lung Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Colorectal Cancer Metastatic
    A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
    Charlottesville Medical Research
    Charlottesville, Virginia 22911
    Overactive Bladder
    A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases
    University of Virginia
    Charlottesville, Virginia 22908
    HER-2 Positive Breast Cancer
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Fungal Infection, Leukemia, Neutropenia
    Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS I
    University of Virginia
    Charlottesville, Virginia 22908
    Lung Cancer
    Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
    University of Virginia
    Charlottesville, Virginia 22908
    Pancreatic Cancer
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    University of Virginia
    Charlottesville, Virginia 22908
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia